1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Transplant Diagnostics Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Transplant Diagnostics Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.1.1. Molecular Assay Technologies
5.2.1.2. Non-Molecular Assay Technologies
5.2.2. By Product & Service
5.2.2.1. Instruments
5.2.2.2. Reagents & Consumables
5.2.2.3. Software & Services
5.2.3. By Application
5.2.3.1. Diagnostic Applications
5.2.3.2. Research applications
5.2.4. By Transplantation Type
5.2.4.1. Solid Organ Transplant
5.2.4.2. Stem Cell Transplantation
5.2.4.3. Soft Tissue Transplantation
5.2.4.4. Bone marrow Transplantation
5.2.5. By End User
5.2.5.1. Independent Reference Laboratories
5.2.5.2. Hospitals & Transplant Centers
5.2.5.3. Research Laboratories & Academic Institutes
5.2.6. By Region
5.2.6.1. North America
5.2.6.2. Europe
5.2.6.3. The Asia Pacific
5.2.6.4. Latin America
5.2.6.5. The Middle East and Africa
6. North America Transplant Diagnostics Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Product
6.2.3. By Application
6.2.4. By Transplantation Type
6.2.5. By End User
6.2.6. By Country
6.2.6.1. United States
6.2.6.2. Canada
7. Europe Transplant Diagnostics Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Product
7.2.3. By Application
7.2.4. By Transplantation Type
7.2.5. By End User
7.2.6. By Country
7.2.6.1. Germany
7.2.6.2. United Kingdom
7.2.6.3. Italy
7.2.6.4. France
7.2.6.5. Spain
7.2.6.6. Rest of Europe
8. Asia Pacific Transplant Diagnostics Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Product
8.2.3. By Application
8.2.4. By Transplantation Type
8.2.5. By End User
8.2.6. By Country
8.2.6.1. China
8.2.6.2. India
8.2.6.3. Japan
8.2.6.4. South Korea
8.2.6.5. Rest of Asia Pacific
9. Latin America Transplant Diagnostics Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Product
9.2.3. By Application
9.2.4. By Transplantation Type
9.2.5. By End User
9.2.6. By Country
9.2.6.1. Brazil
9.2.6.2. Mexico
9.2.6.3. Rest of Latin America
10. Middle East & Africa Transplant Diagnostics Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.3. By Technology
10.4. By Product
10.5. By Application
10.6. By Transplantation Type
10.7. By End User
10.7.1. By Country
10.7.1.1. Saudi Arabia
10.7.1.2. UAE
10.7.1.3. South Africa
10.7.1.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of Covid-19 on Global Transplant Diagnostics Market Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. Abbott Laboratories
13.2. Thermo Fisher Scientific Inc.
13.3. Becton, Dickinson and Company
13.4. Qiagen NV, Biomrieux SA
13.5. Illumina Inc.
13.6. Bio-Rad Laboratories Inc.
13.7. Hologic Inc.
13.8. CareDx
13.9. F Hoffman-La Roche AG
13.10. Takara Bio
13.11. Affymetrix, Inc.
13.12. Olerup Ssp Ab
13.13. Sigma-Aldrich
13.14. Linkage Biosciences
13.15. Other prominent players
14. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable